Refine by
Collagen Content Suppliers Serving Iran
5 companies found
based inMaidstone, UNITED KINGDOM
VivoSight is designed and manufactured by Michelson Diagnostics Ltd. (MDL) in Kent, England. Our flagship product, VivoSight Dx, is a state-of-the art Optical Coherence Tomography (OCT) system. MDL believes that VivoSight OCT images and measurements ...
based inSongpa-gu, SOUTH KOREA
OREON is a specialized anti-aging & medical aesthetic enterprise founded in 2000 Korea. Since 2000, OREON is taking a step further in its commitment to excellence. We have complete product portfolio including filler, thread, cosmeceutical, facial ...
aesPlla is a Poly L-Lactic Acid based injectable dermal filler. This filler has been developed to fill the lost volume with stimulating collagenesis. The main ingredient of aesPlla® PLLA, has been used for more than 20 years in medical devices, ...
based inGlasgow, UNITED KINGDOM
Our mission is to enhance decision making within R&D by leveraging Digital Pathology to deliver robust data and actionable insights. OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and ...
Fast turnaround, accurate data; enabling you to move forward with confidence. Quantitative Digital Pathology provides detailed cell by cell data to enhance decision making in NASH & Fibrosis research. Our dedicated team of image analysis ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
![Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics](https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzEyNTA4Ny9wcm9kdWN0cy84NTMxMzQvMTI1MDg3XzJfMjAyMzAyMTMwNjEwNTM5ODQxNzI5X3Jhdy5wbmciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MTQzLCJoZWlnaHQiOjEwMn19fQ== "Ibio - Model 100 - Idiopathic Pulmonary Fibrosis [IPF] Therapeutics")
Idiopathic pulmonary fibrosis [IPF] is a form of progressive pulmonary fibrosis, or abnormal scarring of the lungs. As the disease progresses, the increased scarring leads to decreasing transfer of oxygen into the bloodstream, and ultimately, ...